Stevens Capital Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $9.35M | Buy |
10,162
+3,491
| +52% | +$3.54M | 1.44% | 16 |
|
|
2025
Q4 | $7.17M | Sell |
6,671
-19,236
| -74% | -$18.4M | 2.52% | 6 |
|
|
2025
Q3 | $19.8M | Buy |
+25,907
| New | +$19.3M | 2.62% | 8 |
|
|
2025
Q2 | – | Sell |
-12,036
| Closed | -$9.94M | – | 296 |
|
|
2025
Q1 | $9.94M | Buy |
+12,036
| New | +$10M | 2.47% | 6 |
|
|
2024
Q4 | – | Sell |
-706
| Closed | -$625K | – | 342 |
|
|
2024
Q3 | $625K | Buy |
+706
| New | +$635K | 0.09% | 105 |
|
|
2024
Q2 | – | Sell |
-9,550
| Closed | -$7.43M | – | 290 |
|
|
2024
Q1 | $7.43M | Buy |
+9,550
| New | +$6.8M | 1.45% | 17 |
|
|
2023
Q4 | – | Sell |
-2,674
| Closed | -$1.44M | – | 300 |
|
|
2023
Q3 | $1.44M | Buy |
+2,674
| New | +$1.38M | 0.41% | 65 |
|
|
2021
Q4 | – | Sell |
-1,961
| Closed | -$453K | – | 259 |
|
|
2021
Q3 | $453K | Buy |
+1,961
| New | +$484K | 0.19% | 99 |
|
|
2020
Q4 | – | Sell |
-23,611
| Closed | -$3.5M | – | 196 |
|
|
2020
Q3 | $3.5M | Buy |
+23,611
| New | +$3.65M | 1.3% | 26 |
|
|
2020
Q1 | – | Sell |
-10,018
| Closed | -$1.32M | – | 240 |
|
|
2019
Q4 | $1.32M | Sell |
10,018
-55,878
| -85% | -$6.48M | 0.12% | 178 |
|
|
2019
Q3 | $7.37M | Sell |
65,896
-207,493
| -76% | -$23.1M | 0.66% | 42 |
|
|
2019
Q2 | $30.3M | Buy |
273,389
+265,899
| +3,550% | +$31.3M | 1.35% | 2 |
|
|
2019
Q1 | $972K | Buy |
+7,490
| New | +$911K | 0.04% | 403 |
|
|
2017
Q1 | – | Sell |
-22,488
| Closed | -$1.65M | – | 992 |
|
|
2016
Q4 | $1.65M | Buy |
+22,488
| New | +$1.67M | 0.07% | 343 |
|
|
2016
Q2 | – | Sell |
-316,622
| Closed | -$22.8M | – | 1021 |
|
|
2016
Q1 | $22.8M | Buy |
316,622
+199,322
| +170% | +$15.1M | 0.9% | 9 |
|
|
2015
Q4 | $9.88M | Buy |
117,300
+112,859
| +2,541% | +$9.37M | 0.39% | 66 |
|
|
2015
Q3 | $372K | Sell |
4,441
-13,844
| -76% | -$1.17M | 0.02% | 620 |
|
|
2015
Q2 | $1.53M | Buy |
18,285
+11,523
| +170% | +$878K | 0.06% | 341 |
|
|
2015
Q1 | $491K | Sell |
6,762
-127,164
| -95% | -$9.05M | 0.02% | 585 |
|
|
2014
Q4 | $9.24M | Buy |
+133,926
| New | +$9.04M | 0.31% | 91 |
|
|
2014
Q1 | – | Sell |
-430,056
| Closed | -$21.9M | – | 1204 |
|
|
2013
Q4 | $21.9M | Sell |
430,056
-248,749
| -37% | -$12.5M | 0.65% | 28 |
|
|
2013
Q3 | $34.2M | Sell |
678,805
-121,923
| -15% | -$6.38M | 1.01% | 9 |
|
|
2013
Q2 | $39.3M | Buy |
+800,728
| New | +$43.6M | 1.31% | 4 |
|
Other funds holding LLY
VCM
VPM
Stevens Capital Management's LLY Position: Q1 2026 in Review
Stevens Capital Management increased its Eli Lilly (LLY) stake by 52% in Q1 2026, buying an estimated $3.54M and bringing the position to 10,162 shares worth $9.35M. The position accounts for 1.44% of the portfolio, ranked #16.
Stevens Capital Management first reported a position in LLY in Q2 2013 and has held it in 23 quarters since. The position peaked at $39.3M in Q2 2013. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Stevens Capital Management held 10,162 shares of Eli Lilly worth $9.35M as of Q1 2026.
- Stevens Capital Management bought 3,491 Eli Lilly shares in Q1 2026, an estimated $3.54M.
- Eli Lilly made up 1.44% of Stevens Capital Management's portfolio in Q1 2026, its #16 holding.
- Stevens Capital Management first reported a position in Eli Lilly in Q2 2013 and has held it in 23 quarters since.
- Stevens Capital Management's Eli Lilly position peaked at $39.3M in Q2 2013.
- 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Stevens Capital Management's 13F filing for Q1 2026, filed 11 May 2026.